Full name
INSIEME 2 SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.78.Z - Retail sale of other new products
49.41.Z - Road freight transport
82.99.Z - Other business support activities, not elsewhere classified
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | 30,2 | -17,4 | 1,5 | 108,8 |
EBITDA | 30,1 | -18,9 | 2,4 | 112,9 |
Short time liabilities | 0,3 | 1,9 | 35,6 | 1738,6 |
Equity capital | 524,5 | 507,9 | 509,1 | 0,2 |
Operating profit (EBIT) | 30,1 | -18,9 | 2,4 | 112,9 |
Assets | 526 | 509,8 | 544,7 | 6,8 |
Net profit (loss) | 28,6 | -16,7 | 1,2 | 107,3 |
Cash | 24,3 | 3,3 | 0 | -100 |
Liabilities and provisions for liabilities | 1,5 | 1,9 | 35,6 | 1738,6 |
Net income from sale | 42 | 42 | 85 | 102,4 |
Working assets | 24,3 | 6,8 | 42 | 515 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 5,5 | -3,3 | 0,2 | 3,5 |
Equity capital to total assets | 99,7 | 99,6 | 93,5 | -6,1 |
Gross profit margin | 71,9 | -41,5 | 1,8 | 43,3 |
EBITDA Margin | 71,6 | -44,9 | 2,9 | 47,8 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 | 17 | 153 | 136 |
Current financial liquidity indicator | 16.701631546020508 | 3.530040740966797 | 1.1807284355163574 | -2,3 |
Net dept to EBITDA | -0.8065469861030579 | 0.17649494111537933 | 12.279958724975586 | 12,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane